Delivery Order SPE2DE24D0013-SPE2D625F1BFV
- Not listed
- The Defense Department's Medical Supply Chain division awarded Cepheid Inc. a $17,952 firm fixed-price delivery order on August 4, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is set to be completed by August 18, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert...
- The Defense Department's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as delivery order XPCOV2/FLU/RSV-10, is scheduled for completion by August 6, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and represents a...
- The Defense Logistics Agency, under its Medical Supply Chain division, awarded a $13,547.30 firm fixed-price delivery order to Cepheid Inc. on August 14, 2025, for respiratory and influenza diagnostic solutions. The contract, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This delivery order carries no set-aside designation and represents procurement under one of Cepheid's existing federal...
- The Defense Department's Medical Supply Chain awarded an $14.55K firm fixed-price delivery order to Cepheid Inc. on August 1, 2025, for molecular diagnostic solutions supporting COVID-19, influenza, and respiratory syncytial virus (RSV) testing capabilities. The contract, with an ultimate completion date of August 8, 2025, represents a delivery order against Cepheid's existing federal contract vehicles and carries no set-aside designation. Performance will be executed at Cepheid's headquarters...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,488 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, which carries an ultimate completion date of August 13, 2025, will be performed at Cepheid's headquarters in Sunnyvale, California. This award includes no set-aside designation and represents a near-term procurement from the Sunnyvale-based molecular...
- The U.S. Defense Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on August 11, 2025, for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This delivery order, with an ultimate completion date of August 18, 2025, carries no set-aside designation and represents a focused procurement of molecular diagnostic products or services from the Sunnyvale, California-based manufacturer. The award likely falls under...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $3,400 firm fixed-price delivery order on July 28, 2025, for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing supplies. The delivery order, contract number 4568910321, is set to be completed by August 4, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract is funded by the Defense Department's Medical Supply Chain entity and utilizes no...
- This delivery order, valued at $40.8K, was awarded to Cepheid Inc. on July 30, 2025, by the Medical Supply Chain office within the Department of Defense. The firm fixed-price contract is for the delivery of molecular diagnostic solutions, specifically supporting COVID-19, influenza, and respiratory syncytial virus (RSV) testing capabilities. The work will be performed in Sunnyvale, California, with an ultimate completion date of August 6, 2025. No set-aside designation was applied to this award....
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1BFVDelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions, specifically related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing capabilities. The delivery order was executed on August 15, 2025, with an ultimate completion date of August 29, 2025, with performance to be conducted at Cepheid's facility in Sunnyvale, California. No set-aside designation was applied to this contract award. This delivery order is likely issued under one of Cepheid's existing indefinite delivery vehicle contracts with the Department of Veterans Affairs, specifically either the $32.8 million single-award IDV with VA's Veterans Integrated Service Network 6 or the $2.5 million IDV with Veterans Integrated Service Network 21, both of which provide molecular diagnostic testing systems, reagents, and assays for conditions including COVID-19, influenza, RSV, and other infectious diseases. Cepheid specializes in GeneXpert diagnostic systems and related testing solutions that support federal healthcare systems' infectious disease detection and diagnostic capabilities across multiple service networks and agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 8/15/25 |